Wuhan Keqian Biology Co Ltd
Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. The company offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China.
Wuhan Keqian Biology Co Ltd (688526) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.042x
Based on the latest financial reports, Wuhan Keqian Biology Co Ltd (688526) has a cash flow conversion efficiency ratio of 0.042x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥174.36 Million) by net assets (CN¥4.17 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Wuhan Keqian Biology Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Wuhan Keqian Biology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Wuhan Keqian Biology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wuhan Keqian Biology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SS Innovations International Inc.
PINK:SSII
|
-0.243x |
|
Villeroy & Boch AG
XETRA:VIB3
|
0.066x |
|
Suzhou Huazhijie Telecom Co
SHG:603400
|
N/A |
|
Vietnam Container Shipping JSC
VN:VSC
|
-0.101x |
|
Jamna Auto Industries Limited
NSE:JAMNAAUTO
|
0.273x |
|
Shijiazhuang Kelin Elec Co
SHG:603050
|
0.182x |
|
Clearpoint Neuro Inc
NASDAQ:CLPT
|
-0.197x |
|
Zhejiang Runyang New Material Technology Co. Ltd.
SHE:300920
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Wuhan Keqian Biology Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Wuhan Keqian Biology Co Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.94 Billion | CN¥392.68 Million | 0.100x | -28.97% |
| 2023-12-31 | CN¥3.84 Billion | CN¥538.03 Million | 0.140x | +15.78% |
| 2022-12-31 | CN¥3.50 Billion | CN¥423.71 Million | 0.121x | -28.11% |
| 2021-12-31 | CN¥3.15 Billion | CN¥531.27 Million | 0.168x | +14.02% |
| 2020-12-31 | CN¥2.71 Billion | CN¥400.14 Million | 0.148x | +6.73% |
| 2019-12-31 | CN¥1.12 Billion | CN¥154.89 Million | 0.138x | -65.52% |
| 2018-12-31 | CN¥876.34 Million | CN¥351.83 Million | 0.401x | -19.92% |
| 2017-12-31 | CN¥673.41 Million | CN¥337.61 Million | 0.501x | -6.16% |
| 2016-12-31 | CN¥413.10 Million | CN¥220.69 Million | 0.534x | -- |